Skip to main content
logo
Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.39
+0.27 (3.33%)
At close: Jan 26, 2026, 4:00 PM EST
8.55
+0.16 (1.91%)
After-hours: Jan 26, 2026, 7:50 PM EST

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $741.00K in the quarter ending September 30, 2025, a decrease of -41.61%. This brings the company's revenue in the last twelve months to $2.65M, down -55.88% year-over-year. In the year 2024, Aligos Therapeutics had annual revenue of $3.95M, down -74.60%.

Revenue (ttm)
$2.65M
Revenue Growth
-55.88%
P/S Ratio
28.09
Revenue / Employee
$37,800
Employees
70
Market Cap
51.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Plus Therapeutics5.26M
NeurAxis3.36M
ABVC BioPharma797.92K
iBio, Inc.500.00K
Impact BioMedical25.00K
Revenue Rankings

ALGS News

More News